Vanguard Group Inc Maravai Lifesciences Holdings, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 11,881,740 shares of MRVI stock, worth $63.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,881,740
Previous 10,748,610
10.54%
Holding current value
$63.3 Million
Previous $77 Million
28.3%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding MRVI
# of Institutions
234Shares Held
140MCall Options Held
223KPut Options Held
19.4K-
Gtcr LLC20.2MShares$107 Million13.05% of portfolio
-
12 West Capital Management LP New York, NY14MShares$74.7 Million12.14% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$51.9 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$44.5 Million1.97% of portfolio
-
Mackenzie Financial Corp Toronto Ontario, A66.36MShares$33.9 Million0.08% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $701M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...